Drug: RHEUMATREX Injury: Lymphoproliferative disorder Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125904792 | RHEUMATREX | Lymphoproliferative disorder | AMGEN | 0.00 | 0 | 20160816 | JP | |
125952062 | RHEUMATREX | Lymphoproliferative disorder | AMGEN | 0.00 | 0 | 20160816 | JP | |
125989262 | RHEUMATREX | Lymphoproliferative disorder | AMGEN | 0.00 | 0 | 20160816 | JP | |
126051581 | RHEUMATREX | Lymphoproliferative disorder | AMGEN | 0.00 | 0 | 20160729 | JP | |
126093781 | RHEUMATREX | Lymphoproliferative disorder | UCB | 7.00 DEC | F | 0 | 20160801 | JP |
126154702 | RHEUMATREX | Lymphoproliferative disorder | AMGEN | 0.00 | 0 | 20160927 | JP | |
127551432 | RHEUMATREX | Lymphoproliferative disorder | JANSSEN | 68.00 YR | M | 0 | 20160930 | JP |
Total Records: 7 Number of Pages: 1